StubsonBWhiteSJ. Survey of pharmacy director's experience with staff vacancies and recruitment. Am J Hosp Pharm1988; 45: 2354–7.
4.
CoeCP. Preparing the pharmacy for a Joint Commission survey. 2nd ed. Bethesda, MD: American Society of Hospital Pharmacists, 1987:2–12.
5.
HoltzmanMS. Clinical pharmacy's time has arrived at the community hospital. Hosp Pharm1989; 24: 958–62.
6.
SikoraRGKotzanJA. Analysis of the change in work patterns following installation of an inpatient pharmacy computer system. Contemp Pharm Pract1981; 4 (3): 160–6.
7.
MossRLPoundersJN. Impact of computerization on dispensing time in an ambulatory care pharmacy. Am J Hosp Pharm1985; 42: 309–12.
8.
StewartRB. Adverse drug reactions. In: BrownTRSmithMC, eds. Handbook of institutional pharmacy practice. Baltimore, MD: Williams & Wilkins, 1986:238.
9.
HaumschildMJWardESBishopMJHaumschildMS. Pharmacy based computer system for monitoring and reporting drug interactions. Am J Hosp Pharm1987; 44: 345–8.
10.
ZaskeDEBootmanJLSolemLB. Increased burn patient survival with individualized dosages of gentamicin. Surgery1982; 39: 142–7.
11.
KimelblattBJBradburyKChodoffL. Cost-benefit analysis of an aminoglycoside monitoring service. Am J Hosp Pharm1986; 43: 1205–9.
12.
BootmanJLWertheimerAIZaskeDERowlandC. Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: A cost-benefit analysis. J Pharm Sci1979; 68: 267–72.
13.
DestacheCJMeyerSKPadomekMTOrtmeierBG. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gram-negative infections. DICP Ann Pharmacother1989; 23: 33–8.
14.
SmithMMurphyJEJobMLWardES. Aminoglycoside monitoring: Use of a pharmacokinetic service versus physician recommendations. Hosp Formul1987; 22: 92–102.
15.
SchloemerJHZagozenJJ. Cost analysis of an aminoglycoside pharmacokinetic dosing service. Am J Hosp Pharm1984; 41: 2347–51.
